SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031636
Filing Date
2024-08-13
Accepted
2024-08-13 16:30:50
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 808666
2 ex31-1.htm EX-31.1 16010
3 ex31-2.htm EX-31.2 16144
4 ex32-1.htm EX-32.1 7833
  Complete submission text file 0001493152-24-031636.txt   4354017

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20240630.xsd EX-101.SCH 31196
6 XBRL CALCULATION FILE brtx-20240630_cal.xml EX-101.CAL 45029
7 XBRL DEFINITION FILE brtx-20240630_def.xml EX-101.DEF 130749
8 XBRL LABEL FILE brtx-20240630_lab.xml EX-101.LAB 295002
9 XBRL PRESENTATION FILE brtx-20240630_pre.xml EX-101.PRE 232839
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 618587
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 301341024 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 241202177
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)